go-v.orgdoi

A Randomized, Double-blind, Single Migraine Attack, Placebo-controlled, Parallel-group Multicenter Study to Evaluate the Efficacy and Tolerability of Trexima (Sumatriptan Succinate.Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain Phase of Menstrual Migraine in Women With Dysmenorrhea

GlaxoSmithKline · Vivli · 2018

  • DOI 10.25934/00000336
  • Publisher Vivli
  • Type dataset
  • Issued 2018

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Vivli · Vivli · dataset · 2018

Abstract

This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine.

Open the resolved locator · 10.25934/00000336

Metadata licence: OpenAlex metadata (CC0)